WCA
LLY icon

Waypoint Capital Advisors’s Eli Lilly LLY Stock Holding History

Waypoint Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.47M Buy
1,656
+43
+3% +$38.7K 0.31% 56
2024
Q2 		$1.46M Buy
1,613
+113
+8% +$90.4K 0.37% 54
2024
Q1 		$1.17M Buy
1,500
+25
+2% +$17.8K 0.31% 58
2023
Q4 		$860K Buy
1,475
+96
+7% +$56K 0.25% 67
2023
Q3 		$741K Buy
1,379
+46
+3% +$23.7K 0.25% 67
2023
Q2 		$625K Buy
1,333
+10
+0.8% +$4.19K 0.2% 83
2023
Q1 		$454K Sell
1,323
-9
-0.7% -$3.04K 0.15% 91
2022
Q4 		$487K Sell
1,332
-43
-3% -$15.2K 0.17% 86
2022
Q3 		$445K Hold
1,375
– – 0.19% 74
2022
Q2 		$446K Hold
1,375
– – 0.2% 71
2022
Q1 		$394K Buy
1,375
+48
+4% +$12.4K 0.23% 77
2021
Q4 		$367K Buy
+1,327
New +$336K 0.25% 67

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Waypoint Capital Advisors's LLY Position: Q3 2024 in Review

Waypoint Capital Advisors increased its Eli Lilly (LLY) stake by 2.7% in Q3 2024, buying an estimated $38.7K and bringing the position to 1,656 shares worth $1.47M. The position accounts for 0.31% of the portfolio, ranked #56.

Waypoint Capital Advisors first reported a position in LLY in Q4 2021 and has held it in 12 quarters since. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Waypoint Capital Advisors held 1,656 shares of Eli Lilly worth $1.47M as of Q3 2024.
  • Waypoint Capital Advisors bought 43 Eli Lilly shares in Q3 2024, an estimated $38.7K.
  • Eli Lilly made up 0.31% of Waypoint Capital Advisors's portfolio in Q3 2024, its #56 holding.
  • Waypoint Capital Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 12 quarters since.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Waypoint Capital Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.